What is the recommended treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of MRSA Infections

For MRSA skin and soft tissue infections, incision and drainage is the primary treatment, with antibiotics added for severe/extensive disease, systemic illness, or surrounding cellulitis; first-line oral options include trimethoprim-sulfamethoxazole, doxycycline, or clindamycin (if local resistance <10%), while vancomycin or daptomycin are preferred for bacteremia and endocarditis. 1

Skin and Soft Tissue Infections (SSTIs)

Simple Abscesses

  • Incision and drainage alone is adequate for simple abscesses without antibiotics 1, 2
  • Obtain cultures from purulent drainage before starting antibiotics to confirm MRSA and guide therapy 2, 3

When to Add Antibiotics to Drainage

Add antibiotics when any of the following are present: 1, 2

  • Severe or extensive disease involving multiple sites
  • Rapid progression with surrounding cellulitis
  • Signs of systemic illness (fever, tachycardia, hypotension)
  • Immunosuppression or significant comorbidities
  • Extremes of age (very young or elderly)
  • Difficult-to-drain locations (face, hand, genitalia)
  • Lack of response to drainage alone

Outpatient Oral Antibiotic Options

For purulent cellulitis (cellulitis with purulent drainage): 1, 3

  • Trimethoprim-sulfamethoxazole (TMP-SMX): 1-2 double-strength tablets orally twice daily 1, 4
  • Doxycycline: 100 mg orally twice daily 1, 2
  • Minocycline: 200 mg loading dose, then 100 mg orally twice daily 3
  • Clindamycin: 300-450 mg orally three times daily (only if local resistance <10%) 1, 3
  • Linezolid: 600 mg orally twice daily (more expensive but highly effective) 1, 3

Important caveat: TMP-SMX and tetracyclines do not adequately cover beta-hemolytic streptococci 1, 3. If coverage for both MRSA and streptococci is needed, use clindamycin alone OR combine TMP-SMX/tetracycline with a beta-lactam (amoxicillin) 1

Treatment duration: 5-10 days for uncomplicated infections 1, 2, 3

Hospitalized Patients with Complicated SSTIs

Intravenous options for severe infections: 1

  • Vancomycin: 15-20 mg/kg/dose IV every 8-12 hours 3
  • Daptomycin: 4 mg/kg/dose IV once daily 1, 5
  • Linezolid: 600 mg IV/PO twice daily 1, 6
  • Telavancin: 10 mg/kg/dose IV once daily 1

Treatment duration: 7-14 days for complicated infections 1, 3

MRSA Bacteremia and Endocarditis

Uncomplicated Bacteremia

Definition: Positive blood cultures with ALL of the following: 1

  • Endocarditis excluded
  • No implanted prostheses
  • Follow-up cultures at 2-4 days negative for MRSA
  • Fever resolves within 72 hours of effective therapy
  • No metastatic infection sites

Treatment options: 1

  • Vancomycin (preferred) 1
  • Daptomycin: 6 mg/kg/dose IV once daily 1
    • Some experts recommend higher doses of 8-10 mg/kg/dose IV once daily 1

Duration: Minimum 2 weeks 1

Complicated Bacteremia

Definition: Patients NOT meeting all criteria for uncomplicated bacteremia 1

Treatment: Same antibiotic options as uncomplicated bacteremia 1

Duration: 4-6 weeks depending on extent of infection 1

Infective Endocarditis

Treatment options: 1

  • Vancomycin IV for 6 weeks 1
  • Daptomycin: 6 mg/kg/dose IV once daily for 6 weeks 1
    • Some experts recommend 8-10 mg/kg/dose IV once daily 1

Critical management steps: 1

  • Obtain blood cultures 2-4 days after initial positive cultures to document clearance 1
  • Perform echocardiography on ALL adult patients with bacteremia; transesophageal echocardiography (TEE) preferred over transthoracic (TTE) 1
  • Identify and eliminate/debride source of infection 1
  • Remove infected intravascular or prosthetic devices (failure to remove increases relapse and mortality) 1

Valve replacement surgery indicated for: 1

  • Large vegetation >10 mm
  • Embolic event during first 2 weeks of therapy
  • Severe valvular insufficiency or perforation
  • Decompensated heart failure
  • Perivalvular or myocardial abscess
  • New heart block
  • Persistent fevers or bacteremia

What NOT to Do for Bacteremia/Endocarditis

  • Do NOT add gentamicin to vancomycin (does not improve outcomes) 1
  • Do NOT add rifampin to vancomycin (does not improve outcomes, increases toxicity and resistance) 1

Pediatric Considerations

Antibiotic dosing for children: 4, 3

  • Clindamycin: 10-13 mg/kg/dose orally every 6-8 hours (maximum 40 mg/kg/day) 4
  • TMP-SMX: 4-6 mg/kg/dose (trimethoprim component) orally every 12 hours 3
  • Vancomycin: Preferred IV agent for severe infections 2

Important restriction: Tetracyclines (doxycycline, minocycline) should NOT be used in children under 8 years of age 4, 3

For pediatric bacteremia: Age-dependent daptomycin dosing showed clinical success of 88% in patients aged 1-17 years: 5

  • Adolescents (12-17 years): 7 mg/kg once daily
  • Children (7-11 years): 9 mg/kg once daily
  • Children (2-6 years): 12 mg/kg once daily

MRSA in Urine

Assessment: Distinguish between asymptomatic bacteriuria, uncomplicated UTI, or complicated UTI with bacteremia 4

Treatment options: 4

  • TMP-SMX: 1-2 double-strength tablets orally twice daily
  • Clindamycin: 300-450 mg orally three times daily

Duration: 4

  • 7-14 days for uncomplicated bacteriuria without systemic symptoms
  • 2-4 weeks for complicated bacteriuria or concurrent bacteremia

Follow-up: Obtain urine cultures 48-72 hours after starting therapy to document clearance 4

Prevention of Recurrence

Basic hygiene measures: 4, 2, 3

  • Keep draining wounds covered with clean, dry bandages
  • Regular handwashing with soap and water or alcohol-based gel
  • Avoid sharing personal items

Decolonization: Consider for patients with recurrent MRSA infections despite optimizing wound care and hygiene 4, 2

  • Mupirocin (nasal application)
  • Chlorhexidine (body wash)

Common Pitfalls to Avoid

  • Never use beta-lactam antibiotics alone for MRSA (they are ineffective by definition) 2
  • Never fail to drain abscesses when present (antibiotics alone will fail regardless of choice) 2
  • Never use rifampin as monotherapy or adjunctive therapy for SSTIs (not recommended) 1, 2
  • Never use daptomycin for pneumonia (it is inactivated by pulmonary surfactant) 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of MRSA Wound Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of MRSA Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of MRSA in Urine Culture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.